ArticleThe Journal of pathology2017

Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.

Victoria L Bridgeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.